BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36165177)

  • 1. Peripheral blood mononuclear cell microRNAs are novel biomarkers for diagnosing and monitoring Crohn's disease.
    Chen H; Li P; Chen J; Wang Y; Yu Q; Wu Y; Chen Y; Cai J
    FASEB J; 2022 Oct; 36(10):e22549. PubMed ID: 36165177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
    Daniluk U; Daniluk J; Krasnodebska M; Lotowska JM; Sobaniec-Lotowska ME; Lebensztejn DM
    Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.
    Chen P; Li Y; Li L; Yu Q; Chao K; Zhou G; Qiu Y; Feng R; Huang S; He Y; Chen B; Chen M; Zeng Z; Zhang S
    Aliment Pharmacol Ther; 2019 Mar; 49(6):733-743. PubMed ID: 30734320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal miR-223 is a noninvasive biomarker for estimating Crohn's disease activity.
    Zhang J; Guo Z; Wang Z; Zhu W; Li Q
    Immun Inflamm Dis; 2023 Dec; 11(12):e1131. PubMed ID: 38156390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.
    Guo G; Wang H; Shi X; Ye L; Wu K; Lin K; Ye S; Li B; Zhang H; Lin Q; Ye S; Xue X; Chen C
    J Transl Med; 2018 Dec; 16(1):370. PubMed ID: 30577810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue and Circulating MicroRNA-31, MicroRNA-200b, and MicroRNA-200c Reflects Disease Activity in Crohn's Disease Patients: Results from the BIOMIR Study.
    Tocia C; Dumitru A; Mateescu B; Negreanu L; State M; Cozaru GC; Mitroi AF; Brinzan C; Popescu R; Leopa N; Iordache MM; Manea M; Matei E; Dumitru E; Alexandrescu L
    J Gastrointestin Liver Dis; 2023 Mar; 32(1):30-38. PubMed ID: 37004230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
    Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F
    Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease.
    Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W
    Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Capsule Endoscopy Crohn's Disease Activity Index, clinical activity and fecal calprotectin level in patients with isolated small intestine lesions].
    Timerbulatov MV; Grishina EE; Aitova LR; Senderovich EI; Ziganshin TM
    Khirurgiia (Mosk); 2021; (9):63-70. PubMed ID: 34480457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Faecal Calprotectin Level and Combined Endoscopic and Radiological Healing in Patients With Crohn's Disease Receiving Anti-tumour Necrosis Factor Therapy.
    Noh SM; Oh EH; Park SH; Lee JB; Kim JY; Park JC; Kim J; Ham NS; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Crohns Colitis; 2020 Sep; 14(9):1231-1240. PubMed ID: 32157278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling microRNA from peripheral blood mononuclear cells in early-onset familial Alzheimer's disease.
    Li D; Chen Y; Zhang T; Lv Z; Zhang L; Li X; Zhang A
    Neuroreport; 2023 Feb; 34(3):178-183. PubMed ID: 36719832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal MicroRNAs Show Promise as Noninvasive Crohn's Disease Biomarkers.
    Wohnhaas CT; Schmid R; Rolser M; Kaaru E; Langgartner D; Rieber K; Strobel B; Eisele C; Wiech F; Jakob I; Gantner F; Herichova I; Vinisko R; Böcher WO; Visvanathan S; Shen F; Panzenbeck M; Raymond E; Reber SO; Delić D; Baum P
    Crohns Colitis 360; 2020 Jan; 2(1):otaa003. PubMed ID: 32551441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Levels of IL-27 Are Associated with Disease Activity in Patients with Crohn's Disease.
    Cui X; Jiao C; Wang D; Ye Z; Ma J; Tang N; Zhang H
    Mediators Inflamm; 2021; 2021():5527627. PubMed ID: 34744512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn's disease.
    Hanžel J; Koželj M; Špes Hlastec A; Kurent T; Sever N; Zdovc J; Smrekar N; Novak G; Štabuc B; Grabnar I; Drobne D
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e831-e836. PubMed ID: 34402470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of peripheral blood mononuclear cell miR-19b-5p, miR- 221, miR-25-5p, and hypertension correlates with an increased heart failure risk in coronary heart disease patients.
    Yao Y; Song T; Xiong G; Wu Z; Li Q; Xia H; Jiang X
    Anatol J Cardiol; 2018 Aug; 20(2):100-109. PubMed ID: 30088484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.